Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Synthetic Biologics, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 2.26||$ 4.32|
|Low||$ 2.16||$ 0.93|
The current last sale of $2.23 is 139.78% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a clinical stage company developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. Our lead product candidates in Phase 2 development are: (1) SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C), and (2) SYN-004, which is designed to protect the gut microbiome (gastrointestinal (GI) microflora) from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD). In collaboration with Intrexon Corporation, we are also developing preclinical stage monoclonal antibody therapies for the prevention and treatment of pertussis, and novel discovery stage biotherapeutics for the treatment of phenylketonuria (PKU). ... More ...
Where does SYN fit in the risk graph?
|Annual EPS Est:||$-0.54|
|Quarterly EPS Est:||-0.13|